Home > Name List By other > (6aR,9R, 10aR)-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-7-prop-2-enyl-6,6a, 8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quino... India

CAS No 81409-90-7 , (6aR,9R,
10aR)-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-7-prop-2-enyl-6,6a,
8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide Search by region : India

  • Name: (6aR,9R,
    10aR)-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-7-prop-2-enyl-6,6a,
    8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
  • Synonyms: Cabergolina; FCE-21336;(6aR,9R,
    10aR)-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-7-prop-2-enyl-6,6a,
    8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide; Cabergolinum; Galastop; Cabergolinum [Latin]; Cabergolina [Spanish]; Cabaseril;Dostinex; Cabaser;
  • CAS Registry Number:
  • Density: 1.156 g/cm3
  • Refractive index: 1.594
  • Water Solubility: Insoluble in water
  • Molecular Weight: 451.60428
  • InchiKey: KORNTPPJEAJQIU-KJXAQDMKSA-N
  • InChI: InChI=1S/C26H37N5O2/c1-5-11-30-17-19(25(32)31(26(33)27-6-2)13-8-12-29(3)
    4)14-21-20-9-7-10-22-24(20)18(16-28-22)15-23(21)30/h5,7,9-10,16,19,21,
    23,28H,1,6,8,11-15,17H2,2-4H3,(H,27,33)/t19-,21-,23-/m1/s1
  • Molecular Formula: C26H37N5O2
  • Molecular Structure:CAS No:81409-90-7 (6aR,9R,<br />10aR)-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-7-prop-2-enyl-6,6a,<br />8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide

Related products

Select to

81409-90-7 Cabergoline

  • IUPAC NAME-N-[3-(Dimethylamino)propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-8g-ergoline-8-carboxamide or 1-[(6-Allylergolin-8β-yl)-carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea MOLECULAR FORMULA-C26H37N5O2 MOLAR MASS-451.604 g/mol hyperprolac...
  • India Swapnroop Drugs and Pharmaceuticals [Manufacturer, Trading Company, Distributor/Wholesaler]
  • Tel: 91-240-6641875
  • Fax: 91-240-6641870
  • Address: Plot No: 04, Mayur Park Road, Harsool Aurangabad,MaharashtraIndia
Contact Supplier

81409-90-7 CABERGOLINE

  • India JAI RADHE SALES null
  • Fax: 0091-79-26569884
  • Address: 309/310 HARIKRUPA TOWER,NR.OLD SHARDA MANDIR CHAR RASTA,ELLISBRIDGE ,AHMEDABAD,GUJRAT , INDIA. null,nullIndia
Contact Supplier

81409-90-7 Cabergoline

  • India Manus Aktteva null
  • Tel: +91-(79)-65123395
  • Fax: +91-(79)-26463395
  • Address: 303, 3rd Floor, Royale Manor, Law Garden, Dhulia Kot Road, Ellisbridge, Ahmedabad, Gujarat 380006, null,nullIndia
Contact Supplier

81409-90-7 Cabergoline

  • India Shreeji Pharma International [Manufacturers]
  • Tel: +91-265-3019110
  • Fax: +91-265-2465036
  • Address: FF/10, Narsinghdham Complex, Sangam Chararasta, Harni Road, Vadodara, Gujarat 390018, Vadodara,GujaratIndia
Contact Supplier

81409-90-7 CABERGOLINE-DIMETHYL ANALOGUE

  • India VARDA Biotech (P) Ltd. [Manufacturer]
  • Tel: +91-22-6693 5686 / 2673 0141 / 2673 4258
  • Fax: +91-22-6693 5687
  • Address: 110 & 111, Kartik Complex
    New link Road, Andheri-(W)
    Mumbai-400053, INDIA. null,nullIndia
Contact Supplier

Select to

1/1
References of (6aR,9R,
10aR)-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-7-prop-2-enyl-6,6a,
8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
Title: Cabergoline
CAS Registry Number: 81409-90-7
CAS Name: (8b)-N-[3-(Dimethylamino)propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)ergoline-8-carboxamide
Synonyms: 1-ethyl-3-(3￠-dimethylaminopropyl)-3-(6￠-allylergoline-8￠b-carbonyl)urea; 1-[(6-allylergoline-8b-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea
Manufacturers' Codes: FCE-21336
Trademarks: Dostinex (Pharmacia & Upjohn)
Molecular Formula: C26H37N5O2
Molecular Weight: 451.60
Percent Composition: C 69.15%, H 8.26%, N 15.51%, O 7.09%
Literature References: Dopamine D2-receptor agonist. Prepn: P. Salvati et al., BE 888243; eidem, US 4526892 (1981, 1985 both to Farmitalia Carlo Erba). Prepn and bioactivity: E. Brambilla et al., Eur. J. Med. Chem. 24, 421 (1989). Clinical pharmacology: C. Ferrari et al., J. Clin. Endocrinol. Metab. 63, 941 (1986). Veterinary trial as abortifacient in dogs: K. Post et al., Theriogenology 29, 1233 (1988). Clinical evaluation to prevent puerperal lactation: G. B. Melis et al., Obstet. Gynecol. 71, 311 (1988); in hyperprolactinemic disorders: C. Ferrari et al., J. Clin. Endocrinol. Metab. 68, 1201 (1989). Clinical trial in Parkinson's disease: J. T. Hutton et al., Neurology 46, 1062 (1996).
Properties: White crystals from diethyl ether, mp 102-104°. Sol in ethyl alcohol, chloroform, DMF; slightly sol in 0.1 N HCl; very slightly sol in n-hexane. Insol in water. LD50 orally in male mice: >400 mg/kg (Brambilla).
Melting point: mp 102-104°
Toxicity data: Sol in ethyl alcohol, chloroform, DMF; slightly sol in 0.1 N HCl; very slightly sol in n-hexane. Insol in water. LD50 orally in male mice: >400 mg/kg (Brambilla)
 
Derivative Type: Diphosphate
CAS Registry Number: 85329-89-1
Molecular Formula: C26H37N5O2.2H3PO4
Molecular Weight: 647.59
Percent Composition: C 48.22%, H 6.69%, N 10.81%, O 24.71%, P 9.57%
Properties: mp 153-155°.
Melting point: mp 153-155°
 
Therap-Cat: Prolactin inhibitor; antiparkinsonian.
Therap-Cat-Vet: Prolactin inhibitor.
Keywords: Antiparkinsonian; Dopamine Receptor Agonist; Prolactin Inhibitor.